The Development of Nonthermal Plasma and Tirapazamine as a Novel Combination Therapy to Treat Melanoma In Situ

被引:3
|
作者
Yehl, Matthew [1 ]
Kucharski, Dominik [1 ]
Eubank, Michelle [1 ]
Gulledge, Brandon [1 ]
Rayan, Gamal [1 ]
Uddin, Md Gias [1 ]
Remmers, Genevieve [2 ]
Kandel, Eugene S. [3 ]
Dufaux, Douglas P. [4 ]
Hutcherson, Timothy C. [1 ]
Sexton, Sandra [3 ]
Zucker, Shoshanna N. [1 ]
机构
[1] DYouville Univ, Sch Pharm, 320 Porter Ave, Buffalo, NY 14201 USA
[2] IDEXX Labs, 1 IDEXX Dr, Westbrook, ME 04092 USA
[3] Roswell Park Comprehens Canc Ctr, 665 Elm St, Buffalo, NY 14203 USA
[4] Alfie Technol Corp, 227 Thorn Ave, Orchard Pk, NY 14127 USA
关键词
nonthermal plasma; tirapazamine; medical device; melanoma; skin cancer; gap junctions; porcine skin; VEMURAFENIB; MECHANISMS; CYTOTOXICITY; COBIMETINIB; CELLS; TUMOR; SKIN;
D O I
10.3390/cells12162113
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Although melanoma accounts for only 5.3% of skin cancer, it results in >75% of skin-cancer-related deaths. To avoid disfiguring surgeries on the head and neck associated with surgical excision, there is a clear unmet need for other strategies to selectively remove cutaneous melanoma lesions. Mohs surgery is the current treatment for cutaneous melanoma lesions and squamous and basal cell carcinoma. While Mohs surgery is an effective way to remove melanomas in situ, normal tissue is also excised to achieve histologically negative margins. This paper describes a novel combination therapy of nonthermal plasma (NTP) which emits a multitude of reactive oxygen species (ROS) and the injection of a pharmaceutical agent. We have shown that the effects of NTP are augmented by the DNA-damaging prodrug, tirapazamine (TPZ), which becomes a free radical only in conditions of hypoxemia, which is often enhanced in the tumor microenvironment. In this study, we demonstrate the efficacy of the combination therapy through experiments with B16-F10 and 1205 Lu metastatic melanoma cells both in vitro and in vivo. We also show the safety parameters of the therapy with no significant effects of the therapy when applied to porcine skin. We show the need for the intratumor delivery of TPZ in combination with the surface treatment of NTP and present a model of a medical device to deliver this combination therapy. The importance of functional gap junctions is indicated as a mechanism to promote the therapeutic effect. Collectively, the data support a novel therapeutic combination to treat melanoma and the development of a medical device to deliver the treatment in situ.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Simultaneous removal of antibiotics and antibiotic resistance genes in wastewater by a novel nonthermal plasma/peracetic acid combination system: Synergistic performance and mechanism
    Zhang, Ai
    Jiang, Xinyuan
    Ding, Yongqiang
    Jiang, Nan
    Ping, Qian
    Wang, Lin
    Liu, Yanan
    JOURNAL OF HAZARDOUS MATERIALS, 2023, 452
  • [42] Combination of nitric oxide therapy, anti-oxidative therapy, low level laser therapy, plasma rich platelet therapy and stem cell therapy as a novel therapeutic application to manage the pain and treat many clinical conditions.
    Halasa, Salaheldin
    Dickinson, Eva
    MECHANISMS FOR LOW-LIGHT THERAPY IX, 2014, 8932
  • [43] USE OF A NOVEL COMBINATION THERAPY PLUS STANDARD OF CARE TO TREAT THREE PATIENTS WITH CHRONIC DIABETIC FOOT ULCERS
    Cheney, Mary
    Shuman, Susan
    Simman, Richard
    JOURNAL OF WOUND OSTOMY AND CONTINENCE NURSING, 2024, 51 (03) : S16 - S16
  • [44] PRECLINICAL INVESTIGATION OF A NOVEL BRAIN PENETRANT COMBINATION THERAPY TARGETING RAF AND MEK FOR MELANOMA BRAIN METASTASIS
    Yamazawa, Erika
    Nayyar, Naema
    Ijad, Nazanin
    Torrini, Consuelo
    Migliarese, Christian
    Summers, Elizabeth
    Marion, Braxton
    Williams, Richard
    Suriben, Rowena
    Perez, Michelle
    Grandinetti, Brooke
    Wakimoto, Hiroaki
    Brastianos, Priscilla
    NEURO-ONCOLOGY, 2024, 26
  • [45] Novel Combination of Silver Nanoparticles and Carbon Nanotubes for Plasmonic Photo Thermal Therapy in Melanoma Cancer Model
    Behnam, Mohammad Ali
    Emami, Farzin
    Sobhani, Zahra
    Koohi-Hosseinabadi, Omid
    Dehghanian, Amir Reza
    Zebarjad, Seyed Mojtaba
    Moghim, Mohammad Hadi
    Oryan, Ahmad
    ADVANCED PHARMACEUTICAL BULLETIN, 2018, 8 (01) : 49 - 55
  • [46] A novel immunogenic mouse model of melanoma for the preclinical assessment of combination targeted and immune-based therapy
    Lelliott, Emily J.
    Cullinane, Carleen
    Martin, Claire A.
    Walker, Rachael
    Ramsbottom, Kelly M.
    Souza-Fonseca-Guimaraes, Fernando
    Abuhammad, Shatha
    Michie, Jessica
    Kirby, Laura
    Young, Richard J.
    Slater, Alison
    Lau, Peter
    Meeth, Katrina
    Oliaro, Jane
    Haynes, Nicole
    McArthur, Grant A.
    Sheppard, Karen E.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [47] A novel immunogenic mouse model of melanoma for the preclinical assessment of combination targeted and immune-based therapy
    Emily J. Lelliott
    Carleen Cullinane
    Claire A. Martin
    Rachael Walker
    Kelly M. Ramsbottom
    Fernando Souza-Fonseca-Guimaraes
    Shatha Abuhammad
    Jessica Michie
    Laura Kirby
    Richard J. Young
    Alison Slater
    Peter Lau
    Katrina Meeth
    Jane Oliaro
    Nicole Haynes
    Grant A. McArthur
    Karen E. Sheppard
    Scientific Reports, 9
  • [48] A novel combination therapy targeting RAF, MEK and FAK to overcome skin cutaneous melanoma treatment resistance
    Lubrano, Simone
    Faraji, Farhoud
    Cervantes-Villagrana, Rodolfo Daniel
    Ramirez, Sydney
    Arang, Nadia
    Officer, Adam
    Rigiracciolo, Damiano C.
    Quiroz, Paola Y. Anguiano
    Bacchiocchi, Antonieta
    Halaban, Ruth
    Coma, Silvia
    Holmen, Sheri
    Martini, Claudia
    Pachter, Jonathan
    Aplin, Andrew
    Gutkind, J. Silvio
    CANCER RESEARCH, 2024, 84 (06)
  • [49] Development of synergistic antifungal in situ gel of miconazole nitrate loaded microemulsion as a novel approach to treat vaginal candidiasis
    Alwan, Omar M.
    Jaafar, Iman S.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [50] Development of novel bi-modal agents for combination use of Auger electron therapy and photodynamic therapy
    Watanabe, Hiroyuki
    Onoue, Ryotaro
    Ono, Masahiro
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65